Figure 3
From: Synthesis, characterization, and evaluation of a novel inhibitor of WNT/β-catenin signaling pathway
BHX inhibits cancer cell proliferation. (A) A549, MGC803, and HT29 cells were treated with BHX at various concentrations, and the response was determined using MTS assay. Data are presented as mean ± SD from three independent experiments. (B) A549 and MGC803 cells were treated with 5 μmol/L BHX for 24 h to 72 h. The β-catenin and E-cadherin levels were measured by western blot assay.